Financial reports
Current reports
8-K
Departure of Directors or Certain Officers
24 Jun 24
8-K
Departure of Directors or Certain Officers
31 May 24
8-K
Departure of Directors or Certain Officers
20 May 24
8-K
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
16 May 24
8-K
Amendments to Articles of Incorporation or Bylaws
9 Apr 24
Registration and prospectus
S-8
Registration of securities for employees
9 Apr 24
424B4
Prospectus supplement with pricing info
5 Apr 24
8-A12B
Registration of securities on exchange
2 Apr 24
S-1/A
IPO registration (amended)
1 Apr 24
S-1
IPO registration
15 Mar 24
DRS/A
Draft registration statement (amended)
15 Feb 24
DRS/A
Draft registration statement (amended)
29 Jan 24
Proxies
No filings